Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Symbiox Investment & Trading Company Ltd has informed the stock exchanges that its Board of Directors will meet on 12 November 2025 at 2:30 PM at the registered office. The key agenda items are to consider and approve the Unaudited Financial Results for the quarter and half year ended 30 September 2025, along with the Limited Review Report from auditors on these results. The notice has been filed under SEBI Listing Regulations. No actual financial numbers have been disclosed in this filing — only an advance intimation of the upcoming board meeting. The company is listed on BSE (Scrip Code 539278), Calcutta Stock Exchange, and MSE.
This is a routine regulatory filing ahead of results announcement and does not directly affect the stock price. Investors should wait for the actual unaudited Q2/H1 FY26 results on or after 12 November 2025 to assess the company's financial performance.